lilly glp-1 injection Diabetes Patients Also Struggle to Access Agonists Eli Lilly Orforglipron Diabetes Trial
Description
doi: 10.1016/S0140-6736(23)01200-X 46 JastreboffAMAronneLJAhmadNNWhartonSConneryLAlvesBet al
Many claims involve patients who experienced sudden vision loss, blurred vision, blind spots, reduced peripheral vision, or permanent visual impairment after using GLP-1 medications
In GLP-1RAs, Semaglutide is better than Dulaglutide in lowering HbA1c concentration (Xie et al., 2023
But GLP-1s should drive both numbers downand the effect applies to both people with and without diabetes
[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Bush M, Scott R, Watanalumlerd P, Zhi H, Lewis E
CAT, catalase
